140 related articles for article (PubMed ID: 37625088)
21. Effects of micronized progesterone added to non-oral estradiol on lipids and cardiovascular risk factors in early postmenopause: a clinical trial.
Casanova G; Spritzer PM
Lipids Health Dis; 2012 Oct; 11():133. PubMed ID: 23046709
[TBL] [Abstract][Full Text] [Related]
22. A prospective randomized comparative study of the effects of intranasal and transdermal 17 beta-estradiol on postmenopausal symptoms and vaginal cytology.
Odabaşi AR; Yüksel H; Demircan SS; Kaçar DF; Culhaci N; Ozkara EE
J Postgrad Med; 2007; 53(4):221-7. PubMed ID: 18097108
[TBL] [Abstract][Full Text] [Related]
23. A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom.
Archer DF; Kimble TD; Lin FDY; Battucci S; Sniukiene V; Liu JH
J Womens Health (Larchmt); 2018 Mar; 27(3):231-237. PubMed ID: 29193980
[TBL] [Abstract][Full Text] [Related]
24. Improvement in sleep outcomes with a 17β-estradiol-progesterone oral capsule (TX-001HR) for postmenopausal women.
Kagan R; Constantine G; Kaunitz AM; Bernick B; Mirkin S
Menopause; 2018 Dec; 26(6):622-628. PubMed ID: 30586005
[TBL] [Abstract][Full Text] [Related]
25. [A randomized case-control study on the influence of percutaneous estradiol and progestin in cyclic combined regimen on endometrium and vaginal bleeding pattern in Chinese early postmenopausal women].
Sun A; Lin S; Wei Y
Zhonghua Yi Xue Za Zhi; 2001 Nov; 81(21):1291-4. PubMed ID: 16200718
[TBL] [Abstract][Full Text] [Related]
26. Association between postmenopausal vulvovaginal discomfort, vaginal microbiota, and mucosal inflammation.
Mitchell CM; Ma N; Mitchell AJ; Wu MC; Valint DJ; Proll S; Reed SD; Guthrie KA; Lacroix AZ; Larson JC; Pepin R; Raftery D; Fredricks DN; Srinivasan S
Am J Obstet Gynecol; 2021 Aug; 225(2):159.e1-159.e15. PubMed ID: 33675793
[TBL] [Abstract][Full Text] [Related]
27. A 17β-Estradiol-Progesterone Oral Capsule for Vasomotor Symptoms in Postmenopausal Women: A Randomized Controlled Trial.
Lobo RA; Archer DF; Kagan R; Kaunitz AM; Constantine GD; Pickar JH; Graham S; Bernick B; Mirkin S
Obstet Gynecol; 2018 Jul; 132(1):161-170. PubMed ID: 29889748
[TBL] [Abstract][Full Text] [Related]
28. A randomized, double-blind, placebo-controlled phase 2 pilot trial evaluating a novel, vaginal softgel capsule containing solubilized estradiol.
Pickar JH; Amadio JM; Hill JM; Bernick BA; Mirkin S
Menopause; 2016 May; 23(5):506-10. PubMed ID: 26836245
[TBL] [Abstract][Full Text] [Related]
29. Relief of vasomotor symptoms and vaginal atrophy with three doses of conjugated estrogens and medroxyprogesterone acetate in postmenopausal Asian women from 11 countries: The Pan-Asia menopause (PAM) study.
Tan D; Haines CJ; Limpaphayom KK; Holinka CF; Ausmanas MK
Maturitas; 2005 Sep; 52(1):35-51. PubMed ID: 16211697
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause.
Labrie F; Archer DF; Koltun W; Vachon A; Young D; Frenette L; Portman D; Montesino M; Côté I; Parent J; Lavoie L; Beauregard A; Martel C; Vaillancourt M; Balser J; Moyneur É;
Menopause; 2016 Mar; 23(3):243-56. PubMed ID: 26731686
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and Tolerability of a Novel 17β-Estradiol and Progesterone Intravaginal Ring in Sheep.
Weiss H; Martell B; Constantine GD; Davis SM; Vidal JD; Mayer PR; Doorbar M; Friend DR
J Pharm Sci; 2019 Aug; 108(8):2677-2684. PubMed ID: 30959058
[TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of a continuous once-a-week 17beta-estradiol/levonorgestrel transdermal system and its effects on vasomotor symptoms and endometrial safety in postmenopausal women: the results of two multicenter, double-blind, randomized, controlled trials.
Shulman LP; Yankov V; Uhl K
Menopause; 2002; 9(3):195-207. PubMed ID: 11973443
[TBL] [Abstract][Full Text] [Related]
33. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints versus estradiol-releasing vaginal ring with a vaginal progesterone suppository: clinical and endometrial responses.
Antoniou G; Kalogirou D; Karakitsos P; Antoniou D; Kalogirou O; Giannikos L
Maturitas; 1997 Mar; 26(2):103-11. PubMed ID: 9089559
[TBL] [Abstract][Full Text] [Related]
34. Effects of E2/P4 oral capsules on bone turnover in women with vasomotor symptoms.
McClung MR; Kagan R; Graham S; Bernick B; Mirkin S; Constantine G
Menopause; 2022 Feb; 29(3):304-308. PubMed ID: 35213517
[TBL] [Abstract][Full Text] [Related]
35. Effects of estradiol with oral or intravaginal progesterone on risk markers for breast cancer in a postmenopausal monkey model.
Wood CE; Sitruk-Ware RL; Tsong YY; Register TC; Lees CJ; Cline JM
Menopause; 2007; 14(4):639-47. PubMed ID: 17224855
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and tolerability of a novel estradiol vaginal ring for relief of menopausal symptoms.
Speroff L
Obstet Gynecol; 2003 Oct; 102(4):823-34. PubMed ID: 14551014
[TBL] [Abstract][Full Text] [Related]
37. Bioavailability and pharmacodynamics of two 10-mg estradiol valerate depot formulations following IM single dose administration in healthy postmenopausal volunteers.
Schug BS; Donath F; Blume HH
Int J Clin Pharmacol Ther; 2012 Feb; 50(2):100-17. PubMed ID: 22257576
[TBL] [Abstract][Full Text] [Related]
38. Breast effects of oral, combined 17β-estradiol, and progesterone capsules in menopausal women: a randomized controlled trial.
Liu JH; Black DR; Larkin L; Graham S; Bernick B; Mirkin S
Menopause; 2020 Dec; 27(12):1388-1395. PubMed ID: 32842052
[TBL] [Abstract][Full Text] [Related]
39. Comparison of a novel vaginal ring delivering estradiol acetate versus oral estradiol for relief of vasomotor menopausal symptoms.
Al-Azzawi F; Buckler HM;
Climacteric; 2003 Jun; 6(2):118-27. PubMed ID: 12841882
[TBL] [Abstract][Full Text] [Related]
40. Low dose of transdermal estradiol gel for treatment of symptomatic postmenopausal women: a randomized controlled trial.
Simon JA; Bouchard C; Waldbaum A; Utian W; Zborowski J; Snabes MC
Obstet Gynecol; 2007 Mar; 109(3):588-96. PubMed ID: 17329509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]